Toncoin-focused treasury company AlphaTON agrees to sell cancer treatment subsidiary

• Immunova is exercising a call option to acquire iOx Therapeutics Limited, a wholly owned AlphaTON subsidiary that develops cancer treatments.

Article Summaries:

• Immunova is exercising a call option to acquire iOx Therapeutics Limited, a wholly owned AlphaTON subsidiary that develops cancer treatments.

Sources:

• https://www.theblock.co/post/390352/toncoin-treasury-company-alphaton-agrees-sell-cancer-treatment-subsidiary?utm_source=rss&utm_medium=rss